Article Details
Retrieved on: 2021-04-05 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The company is equipped to tackle the final manufacturing step for monoclonal antibodies, oligonucleotides and plasmid DNA, as well as adjuvants, ...
Article found on: www.fiercepharma.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here